Related Experiment Video

Updated: Jul 24, 2026

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

Immunosuppression in vitro by a metabolite of a human pathogenic fungus

A Müllbacher, R D Eichner

    Proceedings of the National Academy of Sciences of the United States of America
    |June 1, 1984
    PubMed

    Insights

    Gliotoxin, a fungal toxin, impairs macrophage phagocytosis and blocks cytotoxic T cell development. Its effects are concentration-dependent and specific to early stages of T cell induction.

    Area of Science:

    • Immunology
    • Microbiology
    • Toxicology

    Background:

    • Aspergillus fumigatus is an opportunistic pathogen.
    • Gliotoxin is a key virulence factor produced by A. fumigatus.
    • Understanding gliotoxin's immunomodulatory effects is crucial for disease pathogenesis.

    Purpose of the Study:

    • To investigate the effects of gliotoxin on macrophage function.
    • To determine gliotoxin's impact on cytotoxic T cell induction.
    • To explore the therapeutic potential of overriding gliotoxin's immunosuppression.

    Main Methods:

    • Macrophage phagocytosis assays.
    • Mixed lymphocyte cultures to assess T cell induction.
    • Treatment with varying concentrations of gliotoxin.
    • Analysis of T cell activity and cell-surface antigens.

    Main Results:

    • Gliotoxin inhibits macrophage phagocytosis at 20-50 ng/ml.
    • Pretreatment with 100 ng/ml gliotoxin abrogates cytotoxic T cell induction.
    • Gliotoxin's inhibitory effect is specific to early induction phases.
    • Concanavalin A-activated supernatants can overcome gliotoxin's inhibition.
    • No immediate cell-surface antigen modification on target cells was observed.

    Conclusions:

    • Gliotoxin possesses potent immunosuppressive properties.
    • Its inhibition of T cell development may contribute to A. fumigatus pathogenesis.
    • Targeting gliotoxin or its effects could be a therapeutic strategy.

    More Related Videos

    Establishment of an In vitro System to Study Intracellular Behavior of Candida glabrata in Human THP-1 Macrophages13:47

    Establishment of an In vitro System to Study Intracellular Behavior of Candida glabrata in Human THP-1 Macrophages

    Published on: December 11, 2013

    Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds08:54

    Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

    Published on: February 14, 2018

    Related Concept Videos

    Cell-mediated Immune Responses01:40

    Cell-mediated Immune Responses

    Overview
    Antifungal Agents01:15

    Antifungal Agents

    Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...